The rate of sexually transmitted infections in the United States increased in 2015 for the second year in a row. Adolescents bear an undue portion of this burden because of increased physiologic susceptibility, higher rates of reinfection, and developmental age. Despite expedited partner therapy (EPT) being legalized in 39 states, health care providers still report infrequently providing EPT to their adolescent patients. Patients who benefit most from EPT include those with high-risk sexual behavior, a steady relationship status, higher education level, or an established relationship with the provider. This article will review the barriers to providing EPT and factors associated with patient acceptance or refusal, highlight current legal issues, and discuss the role of the pediatric nurse practitioner addressing specific strategies for implementation in practice. EPT is a valuable tool for the pediatric nurse practitioner to promote treatment and prevent reinfection with sexually transmitted infections.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Pediatric Health Care
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Expedited partner therapy for adolescents diagnosed with chlamydia or gonorrhea: A position paper of the Society for Adolescent Medicine.Journal of Adolescent Health. 2009; 45: 303-309
- Sexually transmitted diseases treatment guidelines, 2015.Morbidity and Mortality Weekly Report. 2015; 46: 55-68
- Legal status of expedited partner therapy (EPT).Author, Atlanta, GA2016 (Retrieved from)
- Sexually transmitted disease surveillance 2015.U.S. Department of Health and Human Services, Atlanta, GA2016
- The legal aspects of expedited partner therapy practice: Do state laws and policies really matter?.Sexually Transmitted Diseases. 2013; 40: 657-662
- Strategies for partner notification for sexually transmitted infections, including HIV.The Cochrane Database of Systematic Reviews. 2013; 10: CD002843
- The cost and cost-effectiveness of expedited partner therapy compared with standard partner referral for the treatment of chlamydia or gonorrhea.Sexually Transmitted Diseases. 2011; 38: 1067-1073
- Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection.New England Journal of Medicine. 2005; 352: 676-685
- Partner notification of sexually transmitted diseases: Practices and preferences.Sexually Transmitted Diseases. 2011; 38: 821-827
- Expedited partner therapy for sexually transmitted disease: Assessing the legal environment.American Journal of Public Health. 2008; 98: 238-243
- Partner services in sexually transmitted disease prevention programs: A review.Sexually Transmitted Diseases. 2016; 43: S53-S62
- Patient-delivered partner therapy for sexually transmitted diseases as practiced by U.S. physicians.Sexually Transmitted Diseases. 2005; 32: 101-105
- Expedited partner therapy in federally qualified health centers—New York City, 2012.Sexually Transmitted Diseases. 2013; 40: 881-885
- Patient-delivered partner therapy for chlamydial infections: Practices, attitudes, and knowledge of California family planning providers.Sexually Transmitted Diseases. 2012; 39: 122-127
- Patient-delivered partner treatment for male urethritis: A randomized, controlled trial.Clinical Infectious Diseases. 2005; 41: 623-629
- Variation in practice of expedited partner therapy for adolescents by state policy environment.Journal of Adolescent Health. 2015; 57: 348-350
- Implementation and effectiveness of an expedited partner therapy program in an urban clinic.Sexually Transmitted Diseases. 2012; 39: 923-929
- EPT for the treatment of Chlamydia trachomatis: Frequently asked question for pharmacists.2016 (Retrieved from)
- Acceptance of and experiences utilising expedited partner therapy among African-American juvenile girls.Sexual Health. 2015; 12: 364-368
- Healthcare providers' perspectives on expedited partner therapy for chlamydia: A qualitative study.Sexually Transmitted Infections. 2015; 91: 407-411
- Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women—A randomized, controlled trial.Sexually Transmitted Diseases. 2003; 30: 49-56
- Predictors of male partner treatment for sexually transmitted infection.Sexually Transmitted Diseases. 2012; 39: 769-775
- Expedited partner therapy: A robust intervention.Sexually Transmitted Diseases. 2010; 37: 602-607
- Use of expedited partner therapy among chlamydia cases diagnosed at an urban Indian health centre, Arizona.International Journal of STD & AIDS. 2013; 24: 371-374
- A qualitative study of patients' use of expedited partner therapy.Sexually Transmitted Diseases. 2011; 38: 651-656
- Adolescent chlamydia infection: Treatment, expedited partner therapy, and testing for reinfection.Clinical Pediatrics. 2015; 54: 1383-1386
- Improved effectiveness of partner notification for patients with sexually transmitted infections: Systematic review.BMJ. 2007; 334: 354
- Adolescent sexuality.Pediatrics in Review. 2013; 34: 29-38
- Predictors of index patient acceptance of expedited partner therapy for Chlamydia trachomatis infection and reasons for refusal, sexually transmitted disease clinics, New York City, 2011 to 2012.Sexually Transmitted Diseases. 2014; 41: 690-694
Lauren M. Hopson, PNP-PC Student, School of Nursing, Columbia University, New York, NY.
Sabrina Opiola McCauley, Assistant Professor of Nursing, School of Nursing, Columbia University, New York, NY.
Published online: February 12, 2017
Conflicts of interest: None to report.
© 2017 by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.